{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955321",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955321_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"acebutolol\" outputclass=\"int-drug\">Acebutolol</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">dobutamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Acebutolol   increases   the risk of hypertension and bradycardia when given with   dobutamine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Acebutolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955322",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955322_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">Dobutamine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"apraclonidine\" outputclass=\"int-drug\">apraclonidine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Dobutamine   is predicted to   decrease   the effects of   apraclonidine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Apraclonidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955323",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955323_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"atenolol\" outputclass=\"int-drug\">Atenolol</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">dobutamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Atenolol   increases   the risk of hypertension and bradycardia when given with   dobutamine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Atenolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955324",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955324_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"betaxolol\" outputclass=\"int-drug\">Betaxolol</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">dobutamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Betaxolol   increases   the risk of hypertension and bradycardia when given with   dobutamine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Betaxolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955325",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955325_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"bisoprolol\" outputclass=\"int-drug\">Bisoprolol</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">dobutamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Bisoprolol   increases   the risk of hypertension and bradycardia when given with   dobutamine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bisoprolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955326",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955326_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"carvedilol\" outputclass=\"int-drug\">Carvedilol</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">dobutamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Carvedilol   increases   the risk of hypertension and bradycardia when given with   dobutamine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Carvedilol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955327",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955327_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"celiprolol\" outputclass=\"int-drug\">Celiprolol</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">dobutamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Celiprolol   increases   the risk of hypertension and bradycardia when given with   dobutamine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Celiprolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955328",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955328_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"entacapone\" outputclass=\"int-drug\">Entacapone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of cardiovascular adverse effects when given with</ph> <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">dobutamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Entacapone   is predicted to   increase   the risk of cardiovascular adverse effects when given with   dobutamine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "8",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Entacapone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955329",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955329_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"esmolol\" outputclass=\"int-drug\">Esmolol</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">dobutamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Esmolol   increases   the risk of hypertension and bradycardia when given with   dobutamine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "9",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Esmolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955330",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955330_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">Dobutamine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of a hypertensive crisis when given with</ph> <ph otherprops=\"isocarboxazid\" outputclass=\"int-drug\">isocarboxazid</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid and for 14 days after stopping the MAOI</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Dobutamine   is predicted to   increase   the risk of a hypertensive crisis when given with   isocarboxazid .  Manufacturer advises avoid and for 14 days after stopping the MAOI .    \n\n"
						}
					],
					"hasOrder": "10",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Isocarboxazid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955331",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955331_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"labetalol\" outputclass=\"int-drug\">Labetalol</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">dobutamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Labetalol   increases   the risk of hypertension and bradycardia when given with   dobutamine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "11",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Labetalol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955332",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955332_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"levobunolol\" outputclass=\"int-drug\">Levobunolol</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">dobutamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Levobunolol   increases   the risk of hypertension and bradycardia when given with   dobutamine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "12",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Levobunolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955333",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955333_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">Dobutamine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of elevated blood pressure when given with</ph> <ph otherprops=\"linezolid\" outputclass=\"int-drug\">linezolid</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Dobutamine   is predicted to   increase   the risk of elevated blood pressure when given with   linezolid .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "13",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Linezolid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955334",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955334_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"metoprolol\" outputclass=\"int-drug\">Metoprolol</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">dobutamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Metoprolol   increases   the risk of hypertension and bradycardia when given with   dobutamine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "14",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Metoprolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955335",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955335_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"nadolol\" outputclass=\"int-drug\">Nadolol</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">dobutamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Nadolol   increases   the risk of hypertension and bradycardia when given with   dobutamine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "15",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nadolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955336",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955336_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"nebivolol\" outputclass=\"int-drug\">Nebivolol</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">dobutamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Nebivolol   increases   the risk of hypertension and bradycardia when given with   dobutamine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "16",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nebivolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955337",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955337_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"opicapone\" outputclass=\"int-drug\">Opicapone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of cardiovascular adverse effects when given with</ph> <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">dobutamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Opicapone   is predicted to   increase   the risk of cardiovascular adverse effects when given with   dobutamine .  Manufacturer advises monitor .    \n\n"
						}
					],
					"hasOrder": "17",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Opicapone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955338",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955338_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">Dobutamine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of a hypertensive crisis when given with</ph> <ph otherprops=\"phenelzine\" outputclass=\"int-drug\">phenelzine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid and for 14 days after stopping the MAOI</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Dobutamine   is predicted to   increase   the risk of a hypertensive crisis when given with   phenelzine .  Manufacturer advises avoid and for 14 days after stopping the MAOI .    \n\n"
						}
					],
					"hasOrder": "18",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Phenelzine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955339",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955339_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"pindolol\" outputclass=\"int-drug\">Pindolol</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">dobutamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Pindolol   increases   the risk of hypertension and bradycardia when given with   dobutamine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "19",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pindolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955340",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955340_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"propranolol\" outputclass=\"int-drug\">Propranolol</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">dobutamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Propranolol   increases   the risk of hypertension and bradycardia when given with   dobutamine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "20",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Propranolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955341",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955341_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">Dobutamine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of a hypertensive crisis when given with</ph> <ph otherprops=\"rasagiline\" outputclass=\"int-drug\">rasagiline</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Dobutamine   is predicted to   increase   the risk of a hypertensive crisis when given with   rasagiline .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "21",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Rasagiline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955342",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955342_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">Dobutamine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of a hypertensive crisis when given with</ph> <ph otherprops=\"safinamide\" outputclass=\"int-drug\">safinamide</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Dobutamine   is predicted to   increase   the risk of a hypertensive crisis when given with   safinamide .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "22",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Safinamide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955343",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955343_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">Dobutamine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of a hypertensive crisis when given with</ph> <ph otherprops=\"selegiline\" outputclass=\"int-drug\">selegiline</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Dobutamine   is predicted to   increase   the risk of a hypertensive crisis when given with   selegiline .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "23",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Selegiline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955344",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955344_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"sotalol\" outputclass=\"int-drug\">Sotalol</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">dobutamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Sotalol   increases   the risk of hypertension and bradycardia when given with   dobutamine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "24",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sotalol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955345",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955345_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"timolol\" outputclass=\"int-drug\">Timolol</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">dobutamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Timolol   increases   the risk of hypertension and bradycardia when given with   dobutamine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "25",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Timolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955346",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955346_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"tolcapone\" outputclass=\"int-drug\">Tolcapone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of cardiovascular adverse effects when given with</ph> <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">dobutamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Tolcapone   is predicted to   increase   the risk of cardiovascular adverse effects when given with   dobutamine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "26",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tolcapone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955347",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2#bnf_i1643857955347_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"dobutamine\" outputclass=\"int-heading-drug\">Dobutamine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of a hypertensive crisis when given with</ph> <ph otherprops=\"tranylcypromine\" outputclass=\"int-drug\">tranylcypromine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid and for 14 days after stopping the MAOI</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Dobutamine   is predicted to   increase   the risk of a hypertensive crisis when given with   tranylcypromine .  Manufacturer advises avoid and for 14 days after stopping the MAOI .    \n\n"
						}
					],
					"hasOrder": "27",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tranylcypromine</title>"
					}
				}
			],
			"hasSearchLabel": " Dobutamine  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/dobutamine-2.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Dobutamine </title>"
			},
			"rdfs:label": "dobutamine"
		}
	]
}